MTD
Mettler-Toledo International Inc
NYSE: MTD · HEALTHCARE · DIAGNOSTICS & RESEARCH
$1,276.61
+2.94% today
Updated 2026-04-30
Market cap
$25.11B
P/E ratio
29.50
P/S ratio
6.24x
EPS (TTM)
$42.04
Dividend yield
—
52W range
$1,049 – $1,525
Volume
0.2M
Mettler-Toledo International Inc (MTD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
21.60%
Operating margin
30.70%
ROE
29.50%
ROA
20.30%
Debt/equity
-99.14x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.59B | $157.53M | 48.84% | 13.44% | 9.88% |
| 2007 | $1.79B | $178.51M | 49.31% | 14.66% | 9.95% |
| 2008 | $1.97B | $202.78M | 49.79% | 15.22% | 10.28% |
| 2009 | $1.73B | $172.59M | 50.76% | 16.35% | 9.98% |
| 2010 | $1.97B | $232.15M | 51.91% | 17.05% | 11.80% |
| 2011 | $2.31B | $269.49M | 51.98% | 16.49% | 11.67% |
| 2012 | $2.34B | $290.85M | 52.10% | 18.08% | 12.42% |
| 2013 | $2.38B | $306.09M | 52.94% | 18.93% | 12.87% |
| 2014 | $2.49B | $338.24M | 53.45% | 19.18% | 13.61% |
| 2015 | $2.40B | $352.82M | 55.67% | 21.44% | 14.73% |
| 2016 | $2.51B | $384.37M | 55.53% | 21.54% | 15.32% |
| 2017 | $2.73B | $375.97M | 56.26% | 22.38% | 13.80% |
| 2018 | $2.94B | $512.61M | 55.76% | 23.27% | 17.46% |
| 2019 | $3.01B | $561.11M | 56.22% | 24.21% | 18.65% |
| 2020 | $3.09B | $602.74M | 56.54% | 25.41% | 19.54% |
| 2021 | $3.72B | $768.99M | 56.71% | 26.76% | 20.68% |
| 2022 | $3.92B | $872.50M | 57.19% | 28.73% | 22.26% |
| 2023 | $3.79B | $788.78M | 59.16% | 30.41% | 20.82% |
| 2024 | $3.87B | $863.14M | 58.17% | 29.11% | 22.29% |
| 2025 | $4.03B | $869.19M | 57.52% | 27.78% | 21.59% |